We are live on
!
Find out more
CS
Credit Suisse Portfolio holdings
AUM
$104B
1-Year Est. Return
34.76%
This Fund
S&P 500
This Quarter
Est. Return
+0.25%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.54%
AUM
$119B
AUM Growth
+$5.64B
(+5%)
Cap. Flow
+$4.85B
Cap. Flow
% of AUM
4.09%
Top 10 Holdings %
Top 10 Hldgs %
16.36%
Holding
4,406
New
331
Increased
2,055
Reduced
1,449
Closed
309
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$1.02B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$944M |
| 3 |
AT&T
T
|
+$753M |
| 4 |
Vanguard Extended Market ETF
VXF
|
+$553M |
| 5 |
Linde
LIN
|
+$379M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
APC
Anadarko Petroleum
APC
|
+$331M |
| 2 |
FDC
First Data Corporation
FDC
|
+$331M |
| 3 |
GWR
Genesee & Wyoming Inc.
GWR
|
+$312M |
| 4 |
Blackstone
BX
|
+$277M |
| 5 |
FirstEnergy
FE
|
+$261M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 34.97% |
| 2 | Healthcare | 11.99% |
| 3 | Technology | 10.99% |
| 4 | Financials | 9.35% |
| 5 | Consumer Discretionary | 6.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BRKL
3001
DELISTED
Brookline Bancorp
BRKL
| $878K | ﹤0.01% |
59,570
+10,437
| +21% | +$151K |
|
3002
Yext
YEXT
$632M
| $877K | ﹤0.01% |
55,136
+3,284
| +6% | +$62.5K |
|
|
MAGN
3003
Magnera Corp
MAGN
$414M
| $877K | ﹤0.01% |
4,384
+941
| +27% | +$188K |
|
3004
CALL
Palo Alto Networks
PANW
$307B
| $876K | ﹤0.01% |
+25,800
| New | +$913K |
|
3005
Shutterstock
SSTK
$183M
| $876K | ﹤0.01% |
24,251
-711
| -3% | -$26.1K |
|
|
TRST
3006
Trustco Bank Corp NY
TRST
$977M
| $873K | ﹤0.01% |
21,429
-224
| -1% | -$8.89K |
|
3007
Zillow
ZG
$7.2B
| $873K | ﹤0.01% |
29,514
+9,775
| +50% | +$387K |
|
3008
PUT
Archer Daniels Midland
ADM
$41B
| $871K | ﹤0.01% |
21,200
-226,300
| -91% | -$9.01M |
|
3009
Invesco S&P 500 Pure Value ETF
RPV
$1.72B
| $871K | ﹤0.01% |
13,426
-42,117
| -76% | -$2.69M |
|
3010
Matthews International
MATW
$623M
| $869K | ﹤0.01% |
24,535
+5,074
| +26% | +$167K |
|
3011
Tennant Co
TNC
$1.16B
| $869K | ﹤0.01% |
12,294
+212
| +2% | +$14.3K |
|
3012
Alaunos Therapeutics
TCRT
$3.25M
| $867K | ﹤0.01% |
1,351
+675
| +100% | +$535K |
|
3013
ePlus
PLUS
$2.41B
| $866K | ﹤0.01% |
22,746
+96
| +0.4% | +$3.7K |
|
|
MNTA
3014
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $866K | ﹤0.01% |
66,760
+1,643
| +3% | +$19.8K |
|
|
NXGN
3015
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $865K | ﹤0.01% |
55,195
+836
| +2% | +$13.9K |
|
|
BRSP
3016
BrightSpire Capital
BRSP
$543M
| $863K | ﹤0.01% |
59,631
+4,156
| +7% | +$60.5K |
|
|
EVOP
3017
DELISTED
EVO Payments, Inc. Class A Common Stock
EVOP
| $863K | ﹤0.01% |
30,642
-7,620
| -20% | -$224K |
|
3018
National Healthcare
NHC
$3.53B
| $861K | ﹤0.01% |
10,520
+1,348
| +15% | +$112K |
|
3019
TFS Financial
TFSL
$4.71B
| $861K | ﹤0.01% |
47,822
+8,803
| +23% | +$158K |
|
|
MIN
3020
Aberdeen Intermediate Income Fund
MIN
$266M
| $860K | ﹤0.01% |
+225,000
| New | +$859K |
|
|
FSCT
3021
DELISTED
ForeScout Technologies, Inc. Common Stock
FSCT
| $860K | ﹤0.01% |
22,703
-108,024
| -83% | -$3.95M |
|
3022
CALL
Hain Celestial
HAIN
$53.2M
| $859K | ﹤0.01% |
40,000
| – | – |
|
|
USCR
3023
DELISTED
U S Concrete, Inc.
USCR
| $858K | ﹤0.01% |
15,533
+764
| +5% | +$35.7K |
|
|
CISN
3024
DELISTED
Cision Ltd. Ordinary Share
CISN
| $857K | ﹤0.01% |
111,334
+14,536
| +15% | +$125K |
|
3025
First Bancorp
FBNC
$2.59B
| $853K | ﹤0.01% |
23,774
+4,719
| +25% | +$169K |
|
Similar funds
CSIA
CAN
VAM
CA
MNG
DPAM
ICG
CW
Credit Suisse's Q3 2019 Portfolio in Review
As of Q3 2019, Credit Suisse held 4,406 positions worth $119B, up 5% from $113B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Credit Suisse deployed $4.85B of net new capital in Q3 2019, opening 331 new positions and adding to 2,055 existing holdings. Its largest new stake was GW Pharmaceuticals Plc American Depositary Shares: 200,027 shares worth $23M.
By sector, the portfolio is most concentrated in Miscellaneous at 35% of assets, up from 34% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was Genesee & Wyoming Inc., an estimated $312M trimmed.
- Credit Suisse's largest Q3 2019 buy was GW Pharmaceuticals Plc American Depositary Shares: 200,027 shares worth $23M.
- Credit Suisse added most to Allergan plc in Q3 2019, an estimated $1.02B increase.
- Credit Suisse's biggest Q3 2019 reduction was Genesee & Wyoming Inc., cutting an estimated $312M.
- Credit Suisse fully exited Anadarko Petroleum in Q3 2019, selling an estimated $331M.
- Credit Suisse's ten largest holdings make up 16% of its $119B portfolio in Q3 2019.
- Credit Suisse opened 331 new positions and closed 309 in Q3 2019.
- Credit Suisse's portfolio value rose 5% quarter-over-quarter to $119B.
Based on Credit Suisse's 13F filing for Q3 2019, filed 12 Nov 2019.